Nephrology Critical CareMurray P, Hall J. Renal replacement therapy for acute renal failure. Am J Respir Crit Care Med 2000; 162:777-81. Concise review of continuous vs. intermittent use of hemodialysis, ultrafiltration, and hemofiltration in hemodynamically stable and unstable patients with ARF. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10988080
Vinsonneau C, Camus C, Combes A, et al. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome. Lancet 2006 ; 368 :379-85. Like previous RCTs addressing this issue, this multicenter study of 360 ICU patients found no advantage to continuous venovenous dialysis in terms of 60-day survival. A limitation of the study is that the delivered dialysis dose may have been suboptimal for both arms. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16876666&query_hl=7&itool=pubmed_docsum
Venkataraman R, Kellum JA. Prevention of acute renal failure. Chest 2007; 131:300-8. This succinct summary of pharmacologic and non-pharmacologic interventions focuses in particular on prevention of contrast nephropathy, including discussions of dopamine, fenoldopam, theophylline, acetylcysteine, and hydration. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17218591&query_hl=35&itool=pubmed_docsum |